Vagisil Disease Interactions
There are 2 disease interactions with Vagisil (benzocaine / resorcinol topical).
Benzocaine (applies to Vagisil) methemoglobinemia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: G-6-PD Deficiency
Rarely, benzocaine has induced methemoglobinemia resulting in respiratory distress and cyanosis. Therapy with benzocaine should be administered cautiously to patients with or predisposed to methemoglobinemia. If life-threatening or severe methemoglobinemia develops, methylene blue infused at a dosage of 1 to 2 mg/kg body weight will rapidly reverse or improve the condition except in G-6-PD-deficient patients.
Resorcinol topical (applies to Vagisil) hypothyroidism
Moderate Potential Hazard, Moderate plausibility.
The use of resorcinol topical has been associated with producing goiter in patients with abraded skin. Therapy with resorcinol topical should be administered cautiously in patients with hypothyroidism. Monitoring thyroid function is recommended in these patients.
Vagisil drug interactions
There are 53 drug interactions with Vagisil (benzocaine / resorcinol topical).
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.